PCRX Pacira BioSciences, Inc. - Common Stock

NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗
$24,52
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 4, 2026

PCRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$24.52
Marktkapitalisierung
$1.19B
P/E (TTM)
180.1
EPS (TTM)
$0.16
Umsatz (TTM)
$726M
Dividendenrendite
ROE
0.97%
Verschuldungsgrad
0.5
52W-Spanne
$19 – $28

PCRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $726M
10-point trend, +162.8%
2016-12-31 2025-12-31
EPS $0.16
10-point trend, +115.7%
2016-12-31 2025-12-31
Freier Cashflow $137M
10-point trend, +1462.9%
2016-12-31 2025-12-31
Margen 0.97%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
PCRX
Peer-Median
P/E (TTM)
5-point trend, +147.3%
180.1
29.9
P/S (TTM) (K/V (TTM))
5-point trend, -70.5%
1.6
14.4
P/B (K/B)
5-point trend, -58.3%
1.7
4.4
EV / EBITDA
2-point trend, +118.0%
12.0
Price / FCF (Kurs / FCF)
5-point trend, -76.9%
8.7

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
PCRX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, -75.5%
2.6%
Net Profit Margin (Nettogewinnmarge)
5-point trend, -97.1%
0.97%
0.70%
ROA
5-point trend, -80.1%
0.50%
-0.55%
ROE
5-point trend, -83.2%
0.97%
-2.5%
ROIC
5-point trend, -91.8%
0.75%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
PCRX
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
2-point trend, -0.8%
0.5
Current Ratio (Liquiditätsgrad)
5-point trend, +173.4%
4.5
3.9
Quick Ratio
5-point trend, +108.1%
3.0

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
PCRX
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, +34.1%
3.6%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, +34.1%
2.9%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, +34.1%
11.1%
EPS YoY (EPS VjV)
5-point trend, -82.6%
161.8%
Net Income YoY (Nettogewinn YoY)
5-point trend, -83.2%
163.7%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
PCRX
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, -82.6%
$0.16

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
PCRX
Peer-Median

PCRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 12 Analysten
  • Starker Kauf 3 25,0%
  • Kauf 5 41,7%
  • Halten 3 25,0%
  • Verkauf 1 8,3%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

6 Analysten · 2026-08-13
Median-Ziel $29.00 +18,3%
Mittelwert-Ziel $30.00 +22,3%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
-0.03%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $0.73 $0.66 0.07%
31. März 2026 $0.60 $0.57 0.03%
31. Dezember 2025 $0.57 $0.92 -0.35%
30. September 2025 $0.70 $0.66 0.04%
30. Juni 2025 $0.74 $0.72 0.02%
31. März 2025 $0.62 $0.61 0.01%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
PCRX $1.06B 161.8 3.6% 0.97% 0.97%
OMER $1.23B -343.6 1.9%
LXRX $421M -8.2 60.2% -101.1% -39.7%
COLL $1.47B 26.8 23.6% 8.1% 23.5% 59.4%
AMPH $1.22B 13.2 -1.7% 13.6% 12.7% 49.5%
ACRS $363M -5.7 -58.2% -829.6% -55.3%
SGP 50.0%
PHAT $1.18B -5.5 216.9% -126.4% 52.4% 87.1%
LLY 46.8 44.7% 31.7% 101.2%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 17
Jährliche Gewinn- und Verlustrechnung-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +267.5% $726M $701M $675M $667M $542M $430M $421M $337M $287M $276M $249M $198M
Cost of Revenue 12-point trend, +93.4% $150M $170M $185M $199M $140M $117M $107M $87M $88M $110M $72M $77M
R&D Expense 12-point trend, +526.3% $117M $82M $76M $85M $56M $59M $72M $56M $57M $46M $29M $19M
SG&A Expense 12-point trend, +245.7% $369M $294M $269M $255M $199M $194M $201M $177M $161M $153M $139M $107M
Operating Expenses 12-point trend, +248.7% $707M $774M $587M $607M $452M $383M $411M $321M $312M $308M $240M $203M
Operating Income 12-point trend, +471.6% $19M $-73M $88M $60M $90M $46M $10M $16M $-25M $-32M $9M $-5M
Interest Expense 10-point trend, +145.3% · · $20M $40M $32M $26M $24M $22M $18M $7M $8M $8M
Interest Income 12-point trend, +5850.8% $23M $20M $11M $5M $896.0K $5M $7M $6M $4M $1M $678.0K $382.0K
Other Non-op 12-point trend, -4063.5% $-7M $-373.0K $-186.0K $-11M $-3M $3M $-5M $-888.0K $167.0K $-82.0K $-165.0K $-159.0K
Pretax Income 12-point trend, +224.6% $17M $-63M $62M $13M $56M $20M $-11M $-425.0K $-42M $-38M $2M $-14M
Income Tax 12-point trend, +5587.9% $10M $36M $20M $-3M $14M $-125M $268.0K $46.0K $140.0K $105.0K $264.0K $173.0K
Net Income 12-point trend, +151.3% $7M $-100M $42M $16M $42M $146M $-11M $-471.0K $-43M $-38M $2M $-14M
EPS (Basic) 12-point trend, +141.0% $0.16 $-2.15 $0.91 $0.35 $0.95 $3.41 $-0.27 $-0.01 $-1.07 $-1.02 $0.05 $-0.39
EPS (Diluted) 12-point trend, +141.0% $0.16 $-2.15 $0.89 $0.34 $0.92 $3.33 $-0.27 $-0.01 $-1.07 $-1.02 $0.04 $-0.39
Shares (Basic) 12-point trend, +26.3% 44,566,000 46,245,000 46,222,000 45,521,000 44,262,000 42,671,000 41,513,000 40,911,000 39,806,000 37,236,000 36,540,000 35,299,000
Shares (Diluted) 12-point trend, +27.6% 45,042,000 46,245,000 51,979,000 46,538,000 45,630,000 43,682,000 41,513,000 40,911,000 39,806,000 37,236,000 41,301,000 35,299,000
EBITDA 12-point trend, +2163.1% $110M $5M $163M $152M $118M $66M $30M $29M $-11M $-19M $21M $5M
Bilanz 30
Jährliche Bilanz-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +322.6% $159M $277M $153M $104M $586M $100M $78M $133M $54M $36M $54M $38M
Short-term Investments 12-point trend, -33.0% $80M $208M $125M $185M $71M $422M $214M $251M $257M $137M $102M $119M
Receivables 12-point trend, +454.7% $124M $113M $106M $98M $96M $53M $48M $38M $32M $30M $26M $22M
Inventory 12-point trend, +422.4% $153M $125M $104M $96M $99M $65M $58M $49M $41M $31M $62M $29M
Prepaid Expense 12-point trend, +631.2% $33M $22M $22M $15M $15M $12M $11M $8M $7M $9M $6M $4M
Current Assets 12-point trend, +155.8% $548M $745M $510M $498M $866M $652M $409M $478M $391M $243M $253M $214M
PP&E (Net) 12-point trend, +132.0% $141M $167M $174M $184M $188M $137M $105M $109M $107M $101M $90M $61M
PP&E (Gross) 12-point trend, +244.8% $278M $300M $309M $301M $274M $215M $180M $170M $156M $139M $115M $81M
Accum. Depreciation 12-point trend, +584.6% $138M $133M $135M $117M $85M $78M $75M $62M $49M $38M $25M $20M
Goodwill 12-point trend, -14.9% $20M $0 $163M $163M $145M $100M $100M $62M $55M $47M $31M $24M
Intangibles 11-point trend, +91240.0% $368M $426M $483M $541M $624M $97M $104M $0 · $0 $81.0K $403.0K
Other Non-current Assets 5-point trend, -74.6% · · · · · · · $657.0K $825.0K $624.0K $406.0K $3M
Total Assets 12-point trend, +287.9% $1.26B $1.55B $1.57B $1.68B $2.08B $1.27B $831M $689M $628M $391M $388M $326M
Accounts Payable 12-point trend, +124.2% $15M $19M $16M $15M $11M $10M $13M $14M $15M $8M $9M $7M
Accrued Liabilities 12-point trend, +237.7% $96M $80M $64M $90M $128M $71M $70M $46M $41M $37M $35M $28M
Current Liabilities 12-point trend, -13.9% $121M $310M $97M $148M $521M $253M $108M $61M $56M $45M $150M $140M
Capital Leases 8-point trend, +36176000.00 $36M $45M $55M $65M $72M $71M $41M $0 · · · ·
Deferred Tax 2-point trend, +4213000.00 $4M $0 · · · · · · · · · ·
Other Non-current Liabilities 12-point trend, +280.3% $21M $17M $14M $10M $20M $4M $2M $17M $16M $19M $11M $5M
Total Liabilities 12-point trend, +269.1% $572M $775M $704M $906M $1.34B $655M $476M $368M $349M $172M $169M $155M
Long-term Debt 7-point trend, +261.0% $372M $585M $522M $689M · · · · · $109M $104M $103M
Total Debt 4-point trend, +210.2% $372M · · · · · · · · $119M $119M $120M
Common Stock 12-point trend, +33.3% $48.0K $47.0K $46.0K $46.0K $45.0K $44.0K $42.0K $41.0K $41.0K $37.0K $37.0K $36.0K
Paid-in Capital 12-point trend, +121.2% $1.06B $1.01B $977M $924M $942M $873M $754M $710M $669M $565M $527M $481M
Retained Earnings 12-point trend, +35.7% $-199M $-206M $-107M $-149M $-212M $-254M $-399M $-388M $-389M $-346M $-308M $-310M
Treasury Stock 3-point trend, +176565000.00 $177M $25M $0 · · · · · · · · ·
AOCI 12-point trend, +5508.8% $4M $343.0K $247.0K $-380.0K $167.0K $318.0K $322.0K $-280.0K $-454.0K $-30.0K $-52.0K $-80.0K
Stockholders' Equity 12-point trend, +305.0% $693M $778M $870M $775M $730M $620M $355M $321M $279M $219M $218M $171M
Liabilities + Equity 12-point trend, +287.9% $1.26B $1.55B $1.57B $1.68B $2.08B $1.27B $831M $689M $628M $391M $388M $326M
Shares Outstanding 12-point trend, +13.7% 41,116,739 47,078,000 46,481,000 45,928,000 44,734,000 43,637,000 41,908,148 41,222,799 40,668,877 37,480,952 36,848,319 36,150,620
Cashflow 18
Jährliche Cashflow-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +807.1% $91M $79M $76M $92M $29M $20M $20M $13M $14M $13M $11M $10M
Stock-based Comp 12-point trend, +131.7% $58M $51M $48M $48M $42M $40M $34M $32M $32M $31M $33M $25M
Deferred Tax 9-point trend, +6477000.00 $6M $21M $16M $-8M $11M $-127M $-2M $0 $0 · · ·
Amort. of Intangibles 12-point trend, +7061.0% $57M $57M $57M $57M $14M $8M $6M $0 $0 $100.0K $300.0K $800.0K
Restructuring 8-point trend, +134.9% $4M $9M $1M $0 $0 $-38.0K $847.0K $2M · · · ·
Other Non-cash 12-point trend, -332.0% $-10M $138M $-26M $-2M $2M $-2M $30M $4M $15M $27M $-18M $4M
Operating Cash Flow 12-point trend, +472.2% $152M $189M $155M $145M $126M $77M $71M $49M $18M $33M $28M $27M
CapEx 12-point trend, -33.3% $15M $11M $15M $30M $46M $38M $10M $15M $19M $25M $40M $23M
Investing Cash Flow 9-point trend, +144.5% $99M $-83M $78M $-225M $-21M $-278M $-128M $21M $-224M · · ·
Debt Issued 3-point trend, -4000.00 · · · · · · · · · $-4.0K $-1M $0
Net Debt Issued 2-point trend, +99.7% · · · · · · · · · $-4.0K $-1M ·
Stock Repurchased 4-point trend, +148328000.00 $148M $25M $0 $0 · · · · · · · ·
Net Stock Activity 2-point trend, -493.3% $-148M $-25M · · · · · · · · · ·
Financing Cash Flow 9-point trend, -264.9% $-370M $17M $-183M $-402M $381M $222M $4M $9M $224M · · ·
Net Change in Cash 8-point trend, -250.8% $-118M $123M $49M $-481M $486M $22M $-54M $78M · · · ·
Taxes Paid 3-point trend, +104.8% $9M $11M $4M · · · · · · · · ·
Free Cash Flow 12-point trend, +3717.3% $137M $179M $139M $115M $80M $39M $60M $34M $-1M $9M $-12M $4M
Levered FCF 10-point trend, +2716.3% · · $126M $67M $56M $-147M $36M $10M $-20M $2M $-19M $-5M
Rentabilität 7
Jährliche Rentabilität-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Operating Margin 11-point trend, +201.1% 2.6% · 13.0% 9.0% 16.6% 10.8% 2.5% 4.7% -8.7% -11.6% 3.8% -2.6%
Net Margin 11-point trend, +114.0% 0.97% · 6.2% 2.4% 7.8% 33.9% -2.6% -0.14% -14.9% -13.7% 0.75% -6.9%
Pretax Margin 11-point trend, +133.9% 2.3% · 9.1% 2.0% 10.4% 4.7% -2.5% -0.13% -14.8% -13.7% 0.85% -6.9%
EBITDA Margin 11-point trend, +516.7% 15.2% · 24.2% 22.7% 21.9% 15.4% 7.1% 8.6% -3.9% -6.9% 8.4% 2.5%
ROA 12-point trend, +109.0% 0.50% -6.4% 2.6% 0.85% 2.5% 13.8% -1.5% -0.07% -8.4% -9.7% 0.52% -5.5%
ROE 12-point trend, +107.5% 0.97% -13.0% 4.9% 2.1% 5.8% 24.2% -3.1% -0.15% -17.1% -17.3% 0.95% -12.9%
ROIC 12-point trend, +141.7% 0.75% -14.9% 6.9% 9.3% 9.2% 54.2% 3.0% 5.5% -8.9% -9.5% 2.5% -1.8%
Liquidität & Solvenz 5
Jährliche Liquidität & Solvenz-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +196.9% 4.5 2.4 5.2 3.4 1.7 2.6 3.8 7.9 7.0 5.4 1.7 1.5
Quick Ratio 12-point trend, +135.1% 3.0 1.9 3.9 2.6 1.4 2.3 3.2 6.9 6.1 4.5 1.2 1.3
Debt / Equity 4-point trend, -23.4% 0.5 · · · · · · · · 0.5 0.5 0.7
LT Debt / Equity 0.5 · · · · · · · · · · ·
Interest Coverage 10-point trend, +792.1% · · 4.3 1.5 2.8 1.8 0.4 0.7 -1.4 -4.5 1.2 -0.6
Effizienz 3
Jährliche Effizienz-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -35.3% 0.5 · 0.4 0.4 0.3 0.4 0.6 0.5 0.6 0.7 0.7 0.8
Inventory Turnover 12-point trend, -68.8% 1.1 1.5 1.8 2.0 1.7 1.9 2.0 1.9 2.4 2.4 1.6 3.5
Receivables Turnover 11-point trend, -42.8% 6.1 · 6.6 6.8 7.3 8.5 9.8 9.7 9.3 9.9 10.3 10.7
Pro Aktie 5
Jährliche Pro Aktie-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +256.1% $16.86 $16.83 $18.72 $16.87 $16.33 $14.20 $8.47 $7.79 $6.87 $5.84 $5.93 $4.73
Revenue / Share 9-point trend, +167.5% $16.13 · $12.99 $14.33 $11.87 $9.84 $10.14 · $7.20 $7.42 $6.03 ·
Cash Flow / Share 10-point trend, +380.6% $3.37 $4.10 $2.98 $3.12 $2.76 $1.76 $1.70 · $0.45 $0.90 $0.70 ·
Cash / Share 12-point trend, +271.5% $3.86 $5.99 $3.30 $2.27 $13.09 $2.29 $1.87 $3.21 $1.33 $0.96 $1.55 $1.04
EPS (TTM) 12-point trend, +141.0% $0.16 $-2.15 $0.89 $0.34 $0.92 $3.33 $-0.27 $-0.01 $-1.07 $-1.02 $0.04 $-0.39
Wachstumsraten 9
Jährliche Wachstumsraten-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -86.1% 3.6% 3.9% 1.2% 23.1% 26.0% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -82.2% 2.9% 9.0% 16.2% · · · · · · · · ·
Revenue CAGR 5Y 11.1% · · · · · · · · · · ·
EPS YoY 3-point trend, +323.5% · · 161.8% -63.0% -72.4% · · · · · · ·
EPS CAGR 3Y 2-point trend, +37.6% -22.2% · -35.6% · · · · · · · · ·
EPS CAGR 5Y -45.5% · · · · · · · · · · ·
Net Income YoY 3-point trend, +330.1% · · 163.7% -62.1% -71.2% · · · · · · ·
Net Income CAGR 3Y 2-point trend, +29.8% -23.8% · -33.9% · · · · · · · · ·
Net Income CAGR 5Y -45.4% · · · · · · · · · · ·
Bewertung (TTM) 14
Jährliche Bewertung (TTM)-Daten für PCRX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +267.5% $726M $701M $675M $667M $542M $430M $421M $337M $287M $276M $249M $198M
Net Income TTM 12-point trend, +151.3% $7M $-100M $42M $16M $42M $146M $-11M $-471.0K $-43M $-38M $2M $-14M
Market Cap 12-point trend, -66.8% $1.06B $871M $1.57B $1.77B $2.69B $2.61B $1.90B $1.77B $1.86B $1.21B $2.83B $3.21B
Enterprise Value 4-point trend, -62.2% $1.20B · · · · · · · · $1.16B $2.79B $3.17B
P/E 12-point trend, +171.2% 161.8 -8.8 37.9 113.6 65.4 18.0 -167.8 -4302.0 -42.7 -31.7 1919.8 -227.3
P/S 12-point trend, -91.0% 1.5 1.2 2.3 2.7 5.0 6.1 4.5 5.3 6.5 4.4 11.4 16.2
P/B 12-point trend, -91.8% 1.5 1.1 1.8 2.3 3.7 4.2 5.3 5.5 6.6 5.5 13.0 18.7
P / Tangible Book 5-point trend, -43.4% 3.5 2.5 7.0 24.9 · 6.2 · · · · · ·
P / Cash Flow 12-point trend, -94.4% 7.0 4.6 10.1 12.2 21.4 33.9 26.9 36.3 104.4 36.2 97.6 125.8
P / FCF 12-point trend, -99.1% 7.8 4.9 11.2 15.4 33.7 66.6 31.5 51.6 -1253.6 138.5 -230.5 895.3
EV / EBITDA 4-point trend, -98.3% 10.9 · · · · · · · · -60.5 133.3 650.6
EV / FCF 4-point trend, -99.0% 8.8 · · · · · · · · 132.3 -227.2 885.0
EV / Revenue 4-point trend, -89.7% 1.6 · · · · · · · · 4.2 11.2 16.0
Earnings Yield 12-point trend, +240.9% 0.62% -11.4% 2.6% 0.88% 1.5% 5.6% -0.60% -0.02% -2.3% -3.2% 0.05% -0.44%

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $726M$701M$675M$667M$542M
Betriebsgewinnmarge % 2.6%13.0%9.0%16.6%
Nettoergebnis $7M$-100M$42M$16M$42M
Verwässerte EPS $0.16$-2.15$0.89$0.34$0.92
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fremdkapital / Eigenkapital 0.5
Liquiditätsgrad 4.52.45.23.41.7
Quick Ratio 3.01.93.92.61.4
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $137M$179M$139M$115M$80M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 267 Einreicher · $788.9M gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
42 (+13 vs. Vorquartal) 23 (-17 vs. Vorquartal) 78 (-4 vs. Vorquartal) 74 (-7 vs. Vorquartal) +4.6M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
Doma Perpetual Capital Management LLC $70.472.634 2.777.794 8,93% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $61.046.258 2.406.238 7,74% Aktien
STATE STREET CORP $52.261.616 2.059.977 6,62% Aktien
DIMENSIONAL FUND ADVISORS LP $51.408.982 2.026.369 6,52% Aktien
D. E. Shaw & Co., Inc. $48.394.315 1.907.541 6,13% Aktien
RENAISSANCE TECHNOLOGIES LLC $43.986.531 1.733.801 5,58% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $42.915.156 1.691.571 5,44% Aktien
GOLDMAN SACHS GROUP INC $29.790.215 1.174.230 3,78% Aktien
AMERICAN CENTURY COMPANIES INC $25.829.019 1.018.093 3,27% Aktien
GEODE CAPITAL MANAGEMENT, LLC $25.588.190 1.008.402 3,24% Aktien
Impax Asset Management Group plc $19.028.185 750.027 2,41% Aktien
TWO SIGMA INVESTMENTS, LP $18.383.203 724.604 2,33% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $17.525.241 690.786 2,22% Aktien
GAGNON SECURITIES LLC $15.440.613 608.617 1,96% Aktien
WELLINGTON MANAGEMENT GROUP LLP $12.178.564 480.038 1,54% Aktien
BRIDGEWAY CAPITAL MANAGEMENT, LLC $10.436.533 411.373 1,32% Aktien
Jefferies Financial Group Inc. $9.389.234 370.092 1,19% Aktien
Hillsdale Investment Management Inc. $9.201.699 362.700 1,17% Aktien
Gagnon Advisors, LLC $8.946.401 352.637 1,13% Aktien
DEUTSCHE BANK AG\ $8.879.779 350.011 1,13% Aktien
EASTERLY INVESTMENT PARTNERS LLC $8.550.172 337.019 1,08% Aktien
Bridge City Capital, LLC $7.922.975 312.297 1,00% Aktien
BARCLAYS PLC $7.825.936 308.472 0,99% Aktien
VANGUARD GROUP INC $7.055.199 272.612 0,89% Aktien
JPMORGAN CHASE & CO $6.850.197 273.025 0,87% Aktien
VANGUARD FIDUCIARY TRUST CO $6.633.164 261.457 0,84% Aktien
MILLENNIUM MANAGEMENT LLC $5.966.085 235.163 0,76% Aktien
Coppell Advisory Solutions LLC $5.592.970 16 0,71% Aktien
VICTORY CAPITAL MANAGEMENT INC $5.562.474 219.254 0,71% Aktien
FMR LLC $5.499.658 216.778 0,70% Aktien
BANK OF AMERICA CORP /DE/ $5.246.592 206.803 0,67% Aktien
Empowered Funds, LLC $5.075.852 200.073 0,64% Aktien
JACOBS LEVY EQUITY MANAGEMENT, INC $5.068.926 199.800 0,64% Aktien
Banco Santander, S.A. $4.211.420 166.000 0,53% Aktien
Robeco Institutional Asset Management B.V. $4.161.036 164.014 0,53% Aktien
BlackRock, Inc. $3.645.035 143.675 0,46% Aktien
AMERIPRISE FINANCIAL INC $3.591.503 141.565 0,46% Aktien
Universal- Beteiligungs- und Servicegesellschaft mbH $3.562.811 140.434 0,45% Aktien
Public Sector Pension Investment Board $3.429.720 135.188 0,43% Aktien
PDT Partners, LLC $3.358.176 132.368 0,43% Aktien
STATE OF WISCONSIN INVESTMENT BOARD $3.292.062 129.762 0,42% Aktien
Man Group plc $3.180.637 125.370 0,40% Aktien
MORGAN STANLEY $2.982.446 117.558 0,38% Aktien
MARTINGALE ASSET MANAGEMENT L P $2.842.075 112.025 0,36% Aktien
Assenagon Asset Management S.A. $2.573.254 101.429 0,33% Aktien
RHUMBLINE ADVISERS $2.513.278 99.066 0,32% Aktien
EXCHANGE TRADED CONCEPTS, LLC $2.505.592 98.762 0,32% Aktien
TWO SIGMA ADVISERS, LP $2.453.424 94.800 0,31% Aktien
RICE HALL JAMES & ASSOCIATES, LLC $2.369.457 93.396 0,30% Aktien
Trexquant Investment LP $2.290.505 90.284 0,29% Aktien
Simplify Asset Management Inc. $2.107.816 83.083 0,27% Aktien
Vanguard Global Advisers, LLC $2.098.403 82.712 0,27% Aktien
PRUDENTIAL FINANCIAL INC $2.022.065 79.703 0,26% Aktien
Russell Investments Group, Ltd. $1.975.536 77.869 0,25% Aktien
NORGES BANK $1.928.120 76.000 0,24% Aktien
Swiss National Bank $1.907.824 75.200 0,24% Aktien
NEW YORK STATE COMMON RETIREMENT FUND $1.857.997 73.236 0,24% Aktien
CITADEL ADVISORS LLC $1.825.600 71.959 0,23% Aktien
KLP KAPITALFORVALTNING AS $1.598.310 63.000 0,20% Aktien
Three Seasons Wealth, LLC $1.596.839 62.942 0,20% Aktien
ExodusPoint Capital Management, LP $1.546.631 60.963 0,20% Aktien
Legal & General Group Plc $1.530.598 60.331 0,19% Aktien
BNP PARIBAS FINANCIAL MARKETS $1.506.597 59.385 0,19% Aktien
CAXTON ASSOCIATES LLP $1.443.984 56.917 0,18% Aktien
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $1.385.516 61.306 0,18% Aktien
MILESTONE ASSET MANAGEMENT, LLC $1.318.149 51.957 0,17% Aktien
PRELUDE CAPITAL MANAGEMENT, LLC $1.284.610 50.635 0,16% Aktien
ALLIANCEBERNSTEIN L.P. $1.145.662 50.693 0,15% Aktien
Integrated Wealth Concepts LLC $1.110.299 43.764 0,14% Aktien
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $1.049.937 41.385 0,13% Aktien
INTECH INVESTMENT MANAGEMENT LLC $1.047.553 41.291 0,13% Aktien
XTX Topco Ltd $1.028.119 40.525 0,13% Aktien
Vinva Investment Management Ltd $1.005.956 27.587 0,13% Aktien
VIRGINIA RETIREMENT SYSTEMS ET Al $987.322 38.150 0,13% Aktien
FIFTH THIRD BANCORP $972.914 38.349 0,12% Aktien
VOYA INVESTMENT MANAGEMENT LLC $964.517 38.018 0,12% Aktien
LAZARD ASSET MANAGEMENT LLC $943.206 37.178 0,12% Aktien
Steward Partners Investment Advisory, LLC $920.246 36.273 0,12% Aktien
SEGALL BRYANT & HAMILL, LLC $885.210 34.892 0,11% Aktien
NATIXIS $862.580 34.000 0,11% Aktien
CITIGROUP INC $845.379 33.322 0,11% Aktien
Legato Capital Management LLC $778.047 30.668 0,10% Aktien
HSBC HOLDINGS PLC $747.369 29.482 0,09% Aktien
LPL Financial LLC $723.654 28.524 0,09% Aktien
Gotham Asset Management, LLC $716.525 28.243 0,09% Aktien
Vident Advisory, LLC $683.544 26.943 0,09% Aktien
VANGUARD ASSET MANAGEMENT, Ltd $671.037 26.450 0,09% Aktien
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $667.612 26.315 0,08% Aktien
HighTower Advisors, LLC $616.948 24.318 0,08% Aktien
RAYMOND JAMES FINANCIAL INC $609.514 24.025 0,08% Aktien
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management $604.872 23.842 0,08% Aktien
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $587.392 23.153 0,07% Aktien
MetLife Investment Management, LLC $586.250 23.108 0,07% Aktien
Quantinno Capital Management LP $568.948 22.426 0,07% Aktien
J. Goldman & Co LP $560.119 22.078 0,07% Aktien
GREENWOOD CAPITAL ASSOCIATES LLC $552.965 21.796 0,07% Aktien
VARCOV Co. $549.260 21.650 0,07% Aktien
Illinois Municipal Retirement Fund $545.633 21.507 0,07% Aktien
Aquatic Capital Management LLC $544.161 21.449 0,07% Aktien
JANUS HENDERSON GROUP PLC $526.776 23.319 0,07% Aktien

Unternehmensinsider 44 Insider · 17 Führungskräfte · 15 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
David M Stack CEO and Chairman 14. Juni 2023 A 186.481 0 0 $0
Max Reinhardt President, Rest of World 7. Juni 2023 S 29.225 0 0 $0
James S Scibetta President 5. Juni 2017 S 25.118 0 0 $0
Scott Braunstein Chief Operating Officer 3. Januar 2018 A 20.982 0 0 $0
Jonathan Slonin Chief Medical Officer 17. August 2026 S 216.384 0 1 $-70.619
Lauren Riker Senior Vice President, Finance 11. Juni 2026 S 62.284 0 1 $-143.702
Kristen Williams Chief Administrative Officer 3. Juni 2026 F 167.062 0 1 $-228.468
Ronald J. Ellis Jr. Chief Strategy Officer 7. Juni 2023 S 30.909 0 0 $0
Dennis Mcloughlin Chief Customer Officer 7. Juni 2023 S 38.115 0 0 $0
Anthony Molloy Chief Lgl & Compliance Officer 6. Juni 2023 S 12.877 0 0 $0
Charles Anthony Laranjeira Chief Technical Officer 14. Juni 2022 M 41.752 0 0 $0
Richard Scranton Chief Scientific Officer 8. November 2019 M 16.061 0 0 $0
Robert J. Weiland Chief Commercial Officer 4. Juni 2018 S 5.088 0 0 $0
James B Jones SVP & Chief Medical Officer 20. November 2017 S 16.823 0 0 $0
Taunia Markvicka SVP, Chief Commercial Officer 17. März 2015 M 8.579 0 0 $0
Gary Patou Chief Medical Officer 7. August 2014 M 0 0 0 $0
John Pratt General Manager, San Diego 13. Juni 2013 M 0 0 0 $0
Marcelo Bigal Direktor 10. Juni 2026 A 17.798 0 0 $0
Alethia Young Direktor 10. Juni 2026 A 17.798 0 0 $0
Christopher Christie Direktor 10. Juni 2026 A 23.059 0 0 $0
Samit Hirawat Direktor 10. Juni 2026 A 6.405 0 0 $0
Mark Froimson Direktor 10. Juni 2026 A 26.541 0 0 $0
Michael J. Yang Direktor 10. Juni 2026 A 19.798 0 0 $0
Laura Brege Direktor 10. Juni 2026 A 30.120 0 0 $0
Thomas G Wiggans Direktor 10. Juni 2026 A 0 0 $0
Yvonne Greenstreet Direktor 8. Juni 2022 A 13.247 0 0 $0
John P Longenecker PHD Direktor 3. März 2022 M 18.823 0 0 $0
Andreas Wicki Direktor 15. März 2021 S 451.324 0 0 $0
Dennis L Winger Direktor 14. Juni 2017 A 7.490 0 0 $0
Fred A Middleton Direktor 24. Juni 2013 S 0 0 0 $0
Luke Evnin Direktor 12. Juni 2013 A 0 0 0 $0
HBM Healthcare Investments (Cayman) Ltd. 10%-Eigentümer 25. März 2013 S 2.233.993 0 0 $0
Abraham Ceesay 4. September 2025 S 9.039 0 1 $-64.005
Mark A. Kronenfeld 11. Juni 2025 A 34.901 0 0 $0
Brendan Teehan 4. Februar 2025 A 54.000 0 0 $0
Frank D. Lee 1. Februar 2025 A 448.409 0 0 $0
Daryl Gaugler 31. Dezember 2024 A 115.443 0 0 $0
Shawn Cross 4. November 2024 A 75.000 0 0 $0
Charles A. Reinhart III 12. Juni 2024 A 51.867 0 0 $0
Paul J Hastings 12. Juni 2024 A 12.724 0 0 $0
Gary W Pace 8. März 2024 S 22.127 0 0 $0
Roy Winston 2. August 2023 S 52.440 0 0 $0
Donald C. Manning 9. Juni 2021 A 29.520 0 0 $0
GORDON CARL L 8. Februar 2011 C 2.828.941 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 16 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
DOMA PERPETUAL CAPITAL MANAGEMENT LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation, DOMA2 LLC, Eric de Armas ×4 Einreichungen 12. März 2026 7,30% Änderung Vorstandskampagne SEC
Consonance Capital Management LP, Consonance Capman GP LLC, Mitchell Blutt ×5 Einreichungen 6. September 2019 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 18. März 2014 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 26. Juli 2013 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 2. April 2013 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 21. März 2013 Erste Einreichung SEC
Sanderling Venture Partners VI, L.P., Sanderling Ventures Management VI, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling VI Limited Partnership, Sanderling Venture Partners VI Co-Investment Fund, L.P., Middleton, McNeil, Mills & Associates VI, LLC, Fred A. Middleton ×4 Einreichungen 21. März 2013 Erste Einreichung Passive Anlage SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 28. September 2012 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 15. Juni 2012 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 19. März 2012 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 1. Dezember 2011 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 1. Dezember 2011 Erste Einreichung Passive Anlage SEC
MPM BioVentures IV-QP, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, Todd Foley, James Paul Scopa, Vaughn M. Kailian, John Vander Vort 29. November 2011 Erste Einreichung Passive Anlage SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 18. Februar 2011 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 18. Februar 2011 Erste Einreichung SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 80 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
PILL · Direxion Shares ETF Trust 1,49% 7.557 NS 30. April 2026 N-PORT
RNIN · EA Series Trust 1,29% 77.493 NS 30. April 2026 N-PORT
SIXS · EXCHANGE TRADED CONCEPTS TRUST 1,15% 62.939 NS 31. Mai 2026 N-PORT
QQQS · Invesco Exchange-Traded Fund Trust … 0,53% 4.821 SH 8. August 2026 Täglich
CAFG · Pacer Funds Trust 0,53% 4.674 NS 30. April 2026 N-PORT
PSCH · Invesco Exchange-Traded Fund Trust … 0,50% 34.147 SH 8. August 2026 Täglich
BRNY · EA Series Trust 0,49% 105.237 NS 30. April 2026 N-PORT
RZG · Invesco Exchange-Traded Fund Trust 0,44% 24.539 SH 8. August 2026 Täglich
SIXL · EXCHANGE TRADED CONCEPTS TRUST 0,44% 35.685 NS 31. Mai 2026 N-PORT
SCOW · Pacer Funds Trust 0,25% 151 NS 30. April 2026 N-PORT
IHE · iShares Trust 0,22% 140.292 SH 8. August 2026 Täglich
XSHQ · Invesco Exchange-Traded Fund Trust … 0,21% 26.878 SH 8. August 2026 Täglich
CALF · Pacer Funds Trust 0,17% 228.340 NS 30. April 2026 N-PORT
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0,16% 37.351 NS 30. April 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,13% 42.794 SH 8. August 2026 Täglich
AFSM · First Trust Exchange-Traded Fund VI… 0,12% 5.078 NS 31. Mai 2026 N-PORT
IJT · iShares Trust 0,11% 366.482 SH 8. August 2026 Täglich
GSSC · Goldman Sachs ETF Trust 0,11% 46.867 NS 31. Mai 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,11% 30.919 SH 8. August 2026 Täglich
VIOG · VANGUARD ADMIRAL FUNDS 0,11% 46.835 SH 8. August 2026 Täglich
FSMD · FIDELITY COVINGTON TRUST 0,11% 101.562 NS 30. April 2026 N-PORT
SMMV · iShares Trust 0,11% 12.284 SH 8. August 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust 0,08% 91.266 SH 8. August 2026 Täglich
DFSV · Dimensional ETF Trust 0,08% 228.455 NS 30. April 2026 N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust … 0,07% 2.141 SH 8. August 2026 Täglich
AVUV · AMERICAN CENTURY ETF TRUST 0,07% 762.506 NS 31. Mai 2026 N-PORT
QVMS · Invesco Exchange-Traded Fund Trust … 0,06% 6.504 SH 8. August 2026 Täglich
XJR · iShares Trust 0,06% 4.673 SH 8. August 2026 Täglich
SMDX · Tidal Trust III 0,06% 3.111 NS 30. April 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0,06% 31.734 SH 8. August 2026 Täglich
IWN · iShares Trust 0,06% 336.803 SH 8. August 2026 Täglich
AVSC · AMERICAN CENTURY ETF TRUST 0,06% 70.645 NS 31. Mai 2026 N-PORT
IJR · iShares Trust 0,06% 2.401.037 SH 8. August 2026 Täglich
ROSC · Lattice Strategies Trust 0,05% 1.091 NS 30. April 2026 N-PORT
VIOO · VANGUARD ADMIRAL FUNDS 0,05% 137.158 SH 8. August 2026 Täglich
RWJ · Invesco Exchange-Traded Fund Trust … 0,05% 40.427 SH 8. August 2026 Täglich
BIB · ProShares Trust 0,05% 1.495 NS 31. Mai 2026 N-PORT
SAA · ProShares Trust 0,04% 492 NS 31. Mai 2026 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0,04% 161.376 NS 31. Mai 2026 N-PORT
VFQY · VANGUARD WELLINGTON FUND 0,04% 7.883 SH 8. August 2026 Täglich
IWM · iShares Trust 0,03% 1.012.844 SH 8. August 2026 Täglich
RSSL · Global X Funds 0,03% 17.676 NS 30. April 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,03% 228.207 SH 8. August 2026 Täglich
ISCV · iShares Trust 0,03% 8.216 SH 8. August 2026 Täglich
DFAT · Dimensional ETF Trust 0,03% 159.088 NS 30. April 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 0,03% 20.231 SH 8. August 2026 Täglich
EBIT · Harbor ETF Trust 0,02% 109 NS 30. April 2026 N-PORT
DFAS · Dimensional ETF Trust 0,02% 131.931 NS 30. April 2026 N-PORT
ITWO · ProShares Trust 0,02% 1.922 NS 31. Mai 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,02% 200.073 NS 31. Mai 2026 N-PORT